- Home
- DLHC vs BYSI Comparison
DLHC vs BYSI Comparison
Compare DLHC & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLHC
- BYSI
- Stock Information
- Founded
- DLHC 1969
- BYSI 2010
- Country
- DLHC United States
- BYSI United States
- Employees
- DLHC N/A
- BYSI N/A
- Industry
- DLHC Business Services
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- DLHC Consumer Discretionary
- BYSI Health Care
- Exchange
- DLHC Nasdaq
- BYSI Nasdaq
- Market Cap
- DLHC 74.2M
- BYSI 71.0M
- IPO Year
- DLHC N/A
- BYSI 2017
- Fundamental
- Price
- DLHC $5.51
- BYSI $3.15
- Analyst Decision
- DLHC
- BYSI
- Analyst Count
- DLHC 0
- BYSI 0
- Target Price
- DLHC N/A
- BYSI N/A
- AVG Volume (30 Days)
- DLHC 46.8K
- BYSI 140.7K
- Earning Date
- DLHC 07-30-2025
- BYSI 08-11-2025
- Dividend Yield
- DLHC N/A
- BYSI N/A
- EPS Growth
- DLHC 75.08
- BYSI N/A
- EPS
- DLHC 0.38
- BYSI N/A
- Revenue
- DLHC $377,074,000.00
- BYSI N/A
- Revenue This Year
- DLHC N/A
- BYSI N/A
- Revenue Next Year
- DLHC N/A
- BYSI N/A
- P/E Ratio
- DLHC $14.52
- BYSI N/A
- Revenue Growth
- DLHC N/A
- BYSI N/A
- 52 Week Low
- DLHC $2.72
- BYSI $0.98
- 52 Week High
- DLHC $11.99
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- DLHC 63.84
- BYSI 72.10
- Support Level
- DLHC $5.32
- BYSI $2.73
- Resistance Level
- DLHC $5.66
- BYSI $3.44
- Average True Range (ATR)
- DLHC 0.24
- BYSI 0.33
- MACD
- DLHC -0.03
- BYSI 0.12
- Stochastic Oscillator
- DLHC 72.60
- BYSI 81.49
About DLHC DLH Holdings Corp.
DLH Holdings Corp is a provider of technology-enabled business process outsourcing and program management solutions in the United States. The company offers services to several government agencies which include the Department of Veteran Affairs. The company is engaged in public health, performance evaluation, and health operations to solve the complex problems faced by civilian and military customers alike, leveraging digital transformation, artificial intelligence, analytics, cloud-based applications, telehealth systems, and others.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.